Organoid-on-a-chip (OrgOC): Advancing cystic fibrosis research

Area of Science:

• Biomedical Engineering
• Genetics and Genomics
• Cell Biology

Background:

• Cystic Fibrosis (CF) is a complex genetic disorder affecting multiple organs due to impaired anion transport.
• The genetic heterogeneity of CF presents significant challenges for developing effective, one-size-fits-all treatments.
• Individualized therapeutic strategies are increasingly crucial for managing CF effectively.

Purpose of the Study:

• To review the technological evolution of patient-derived organoids and organ-on-a-chip (OOC) platforms for Cystic Fibrosis research.
• To highlight recent advancements in applying these models to basic CF research.
• To focus on organoid-on-a-chip (OrgOC) systems for understanding CF pathogenesis and evaluating therapeutic interventions.

Main Methods:

• Systematic review of technological development in CF organoid and OOC models.
• Analysis of recent applications in CF basic research.
• Exploration of organoid-on-a-chip (OrgOC) systems for CF pathogenesis and therapy assessment.

Main Results:

• Patient-derived organoids and OOC platforms show high fidelity in recapitulating CF pathology.
• These in vitro models facilitate cost-effective, high-throughput screening for personalized CF therapies.
• OrgOC systems are emerging as powerful tools for elucidating CF mechanisms and testing treatment efficacy.

Conclusions:

• Organoid and OOC technologies represent significant progress in CF research and drug development.
• These advanced models are essential for advancing personalized medicine approaches in Cystic Fibrosis.
• Future research utilizing OrgOC systems promises deeper insights into CF and novel therapeutic strategies.